Cathie Wood and Ark Invest sold roughly $7,379,804 worth of Palantir stock — and spent $9,145,824 on three biotech stocks.

EST Cathie Wood’s ARK Investment buys 187K shares of Crispr Therapeutics (CRSP) todayMaximize Your Portfolio with Data Driven ...

Cathie Wood saw her investments rally in the second half of 2024 after a slow start. The co-founder, CEO, and primary stock picker for Ark Invest is hoping to jump ahead of the market early this year.

Cathie Wood, CEO and CIO of Ark Invest, highlighted that one of the dominant themes of 2025 will be ongoing investment in ...

Cathie Wood has a reputation for big wagers on technology, and she earned her reputation after returning 153% in 2020. She did well in 2021 too, but the spotlight slowly moved away as most tech ...

Feb. 4, 2025, Cathie Wood-led Ark Invest dumped $7.4 million worth of Palantir stock even as the shares rose 24% over ...

Don’t look now, but Cathie Wood of Ark Invest is fresh off an impressive comeback year, with her broader basket of disruptive technology funds posting high double-digit percentage returns.

Cathie Wood bounced back in 2024. The growth investor who rocked the world in 2020 with her market-thumping returns at Ark Invest has proved to be mortal in subsequent years. However, a couple of ...

Cathie Wood has a reputation for big wagers on technology, and she earned her reputation after returning 153% in 2020. She did well in 2021 too, but the spotlight slowly moved away as most tech ...

Cathie Wood added to her stakes in Amazon, GitLab, and PacBio on Monday. Amazon has been riding the bullish momentum as a "Magnificent Seven" stock, but net sales growth is unlikely to top 12% for ...